ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Association of LIGHT polymorphism with response to warfarin therapy in bbrazilian individuals (2013)
Borges, Jessica Bassabi; Maureira, Alvaro Danilo Cerda; Fajardo, Cristina Moreno ; Castro, Lara Reinel de; Sampaio, Marcelo Ferraz; Santos, Jessica Cassilla dos; Wang, Hui-Tzu Lin; Lima, Paula Helena Ortiz; Correia, Gabriel Kenji Vemoto Toller; Dietzius, Andrea Marçal; Oliveira, Caroline Nascimento Barbosa; Sousa, Amanda Guerra de Moraes Rego; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Drug Metabolism and Drug Interactions. Conference titles: ESPT Conference Pharmacogenomics: From Cell to Clinic. Unidade: FCF
Assunto: POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Jessica Bassabi et al. Association of LIGHT polymorphism with response to warfarin therapy in bbrazilian individuals. Drug Metabolism and Drug Interactions. Lisboa: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 11 nov. 2024. , 2013
APA
Borges, J. B., Maureira, A. D. C., Fajardo, C. M., Castro, L. R. de, Sampaio, M. F., Santos, J. C. dos, et al. (2013). Association of LIGHT polymorphism with response to warfarin therapy in bbrazilian individuals. Drug Metabolism and Drug Interactions. Lisboa: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Borges JB, Maureira ADC, Fajardo CM, Castro LR de, Sampaio MF, Santos JC dos, Wang H-TL, Lima PHO, Correia GKVT, Dietzius AM, Oliveira CNB, Sousa AG de MR, Hirata RDC, Hirata MH. Association of LIGHT polymorphism with response to warfarin therapy in bbrazilian individuals. Drug Metabolism and Drug Interactions. 2013 ; 28( 3): A46-A47.[citado 2024 nov. 11 ]
Vancouver
Borges JB, Maureira ADC, Fajardo CM, Castro LR de, Sampaio MF, Santos JC dos, Wang H-TL, Lima PHO, Correia GKVT, Dietzius AM, Oliveira CNB, Sousa AG de MR, Hirata RDC, Hirata MH. Association of LIGHT polymorphism with response to warfarin therapy in bbrazilian individuals. Drug Metabolism and Drug Interactions. 2013 ; 28( 3): A46-A47.[citado 2024 nov. 11 ]
Trabalho de evento-resumo periodico
Contribution of polymorphisms in VKORC1, CY2C9 and other candidate genes on therapeutic management of warfarin (2013)
Hirata, Thiago Dominguez Crespo; Borges, Jessica Bassabi; Castro, Lara Reinel de; Sampaio, Marcelo Ferraz; Fajardo, Cristina Moreno ; Maureira, Alvaro Danilo Cerda; Wang, Hui-Tzu Lin; Santos, Jessica Cassilla dos; Lima, Paula Helena Ortiz; Correia, Gabriel Kenji Vemoto Toller; Dietzius, Andrea Marçal; Oliveira, Caroline Nascimento Barbosa; Sousa, Amanda Guerra de Moraes Rego; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Drug Metabolism and Drug Interactions. Conference titles: Second ESPT Conference "Pharmacogenomics: From Cell to Clinic". Unidade: FCF
Assunto: POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Thiago Dominguez Crespo et al. Contribution of polymorphisms in VKORC1, CY2C9 and other candidate genes on therapeutic management of warfarin. Drug Metabolism and Drug Interactions. Lisboa: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 11 nov. 2024. , 2013
APA
Hirata, T. D. C., Borges, J. B., Castro, L. R. de, Sampaio, M. F., Fajardo, C. M., Maureira, A. D. C., et al. (2013). Contribution of polymorphisms in VKORC1, CY2C9 and other candidate genes on therapeutic management of warfarin. Drug Metabolism and Drug Interactions. Lisboa: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Hirata TDC, Borges JB, Castro LR de, Sampaio MF, Fajardo CM, Maureira ADC, Wang H-TL, Santos JC dos, Lima PHO, Correia GKVT, Dietzius AM, Oliveira CNB, Sousa AG de MR, Hirata MH, Hirata RDC. Contribution of polymorphisms in VKORC1, CY2C9 and other candidate genes on therapeutic management of warfarin. Drug Metabolism and Drug Interactions. 2013 ; 28( 3):[citado 2024 nov. 11 ]
Vancouver
Hirata TDC, Borges JB, Castro LR de, Sampaio MF, Fajardo CM, Maureira ADC, Wang H-TL, Santos JC dos, Lima PHO, Correia GKVT, Dietzius AM, Oliveira CNB, Sousa AG de MR, Hirata MH, Hirata RDC. Contribution of polymorphisms in VKORC1, CY2C9 and other candidate genes on therapeutic management of warfarin. Drug Metabolism and Drug Interactions. 2013 ; 28( 3):[citado 2024 nov. 11 ]
Trabalho de evento-resumo periodico
Statins deregulate microRNA expression signature in HepG2 cells (2013)
Salazar, Luiz; Zambrano, Tomás; Hirata, Mario Hiroyuki ; Cerda, Alvaro; Hirata, Rosario Dominguez Crespo
Source: Drug Metabolism and Drug Interactions. Conference titles: ESPT Conference Pharmacogenomics: From Cell to Clinic. Unidade: FCF
Subjects: HIPERCOLESTEROLEMIA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALAZAR, Luiz et al. Statins deregulate microRNA expression signature in HepG2 cells. Drug Metabolism and Drug Interactions. Lisboa: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 11 nov. 2024. , 2013
APA
Salazar, L., Zambrano, T., Hirata, M. H., Cerda, A., & Hirata, R. D. C. (2013). Statins deregulate microRNA expression signature in HepG2 cells. Drug Metabolism and Drug Interactions. Lisboa: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Salazar L, Zambrano T, Hirata MH, Cerda A, Hirata RDC. Statins deregulate microRNA expression signature in HepG2 cells. Drug Metabolism and Drug Interactions. 2013 ; 28( 3): A40.[citado 2024 nov. 11 ]
Vancouver
Salazar L, Zambrano T, Hirata MH, Cerda A, Hirata RDC. Statins deregulate microRNA expression signature in HepG2 cells. Drug Metabolism and Drug Interactions. 2013 ; 28( 3): A40.[citado 2024 nov. 11 ]
Artigo de periodico
ABCA1 and ABCG1 expressions are regulated by statins and ezetimibe in Caco-2 cells (2011)
Genvigir, Fabiana Dalla Vecchia; Rodrigues, Alice Cristina ; Cerda, Alvaro; Hirata, Mario Hiroyuki ; Curi, Rui; Hirata, Rosario Dominguez Crespo
Source: Drug Metabolism and Drug Interactions. Unidades: FCF, ICB
Subjects: LIPOPROTEÍNAS LDL, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. ABCA1 and ABCG1 expressions are regulated by statins and ezetimibe in Caco-2 cells. Drug Metabolism and Drug Interactions, v. 26, n. 1, p. 33-36, 2011Tradução . . Disponível em: https://doi.org/10.1515/DMDI.2011.101. Acesso em: 11 nov. 2024.
APA
Genvigir, F. D. V., Rodrigues, A. C., Cerda, A., Hirata, M. H., Curi, R., & Hirata, R. D. C. (2011). ABCA1 and ABCG1 expressions are regulated by statins and ezetimibe in Caco-2 cells. Drug Metabolism and Drug Interactions, 26( 1), 33-36. doi:10.1515/DMDI.2011.101
NLM
Genvigir FDV, Rodrigues AC, Cerda A, Hirata MH, Curi R, Hirata RDC. ABCA1 and ABCG1 expressions are regulated by statins and ezetimibe in Caco-2 cells [Internet]. Drug Metabolism and Drug Interactions. 2011 ; 26( 1): 33-36.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1515/DMDI.2011.101
Vancouver
Genvigir FDV, Rodrigues AC, Cerda A, Hirata MH, Curi R, Hirata RDC. ABCA1 and ABCG1 expressions are regulated by statins and ezetimibe in Caco-2 cells [Internet]. Drug Metabolism and Drug Interactions. 2011 ; 26( 1): 33-36.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1515/DMDI.2011.101
Artigo de periodico
Tumor necrosis factor-'alpha' and interleukin-6 expression in leukocytes and their association with polymorphisms and bone markers in diabetic individuals treated with pioglitazone (2011)
Himelfarb, Silvia Tchernin; Silva, Fernanda Abujamra; Arazi, Simone Sorkin; Farjado, Cristina M; Garofalo, Adriana; Bertolami, Marcelo C; Bertolami, Adriana; Faludi, André Arpad; Sampaio, Marcelo Ferraz; Rezende, Adriana Augusto de; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Drug Metabolism and Drug Interactions. Unidade: FCF
Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, INTERLEUCINA 1, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIMELFARB, Silvia Tchernin et al. Tumor necrosis factor-'alpha' and interleukin-6 expression in leukocytes and their association with polymorphisms and bone markers in diabetic individuals treated with pioglitazone. Drug Metabolism and Drug Interactions, v. 26, n. 1, p. 37-40, 2011Tradução . . Disponível em: https://doi.org/10.1515/DMDI.2011.100. Acesso em: 11 nov. 2024.
APA
Himelfarb, S. T., Silva, F. A., Arazi, S. S., Farjado, C. M., Garofalo, A., Bertolami, M. C., et al. (2011). Tumor necrosis factor-'alpha' and interleukin-6 expression in leukocytes and their association with polymorphisms and bone markers in diabetic individuals treated with pioglitazone. Drug Metabolism and Drug Interactions, 26( 1), 37-40. doi:10.1515/DMDI.2011.100
NLM
Himelfarb ST, Silva FA, Arazi SS, Farjado CM, Garofalo A, Bertolami MC, Bertolami A, Faludi AA, Sampaio MF, Rezende AA de, Hirata RDC, Hirata MH. Tumor necrosis factor-'alpha' and interleukin-6 expression in leukocytes and their association with polymorphisms and bone markers in diabetic individuals treated with pioglitazone [Internet]. Drug Metabolism and Drug Interactions. 2011 ; 26( 1): 37-40.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1515/DMDI.2011.100
Vancouver
Himelfarb ST, Silva FA, Arazi SS, Farjado CM, Garofalo A, Bertolami MC, Bertolami A, Faludi AA, Sampaio MF, Rezende AA de, Hirata RDC, Hirata MH. Tumor necrosis factor-'alpha' and interleukin-6 expression in leukocytes and their association with polymorphisms and bone markers in diabetic individuals treated with pioglitazone [Internet]. Drug Metabolism and Drug Interactions. 2011 ; 26( 1): 37-40.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1515/DMDI.2011.100

USP Schools

ReP

Filtros

Authors

Subjects